dokomo
Ex-Bluelighter
- Joined
- Feb 15, 2008
- Messages
- 5,589
From the site:
Link
Press Release (PDF)
Research Poster (PDF)
NKTR-181 is a mu-opioid analgesic investigational drug candidate with a novel molecular structure designed to provide potent pain relief while reducing the serious side effects of respiratory depression, sedation and abuse potential associated with conventional opioids.
...
The unique molecular design of the polymer drug conjugate also prevents conversion of NKTR-181 into a rapid-acting abusable form of an opioid. As a result, NKTR-181 has the potential to be a highly effective analgesic with a highly favorable safety profile and reduced abuse potential.
Link
Press Release (PDF)
Research Poster (PDF)

